In a big data perspective, combined with the forecasted progress in immune and molecular methods, data generated from ANA pattern assays will probably provide precious contribution in the elucidation of the immunological mechanisms and their clinical and therapeutic implications in SLE. This evidence concerns the gene BTG3 and systemic lupus erythematosus.